Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Formoterol, Beclometason, Glycopyrronium, F. D. Z. 01.11.25 - 31.10.26 (plus Extension Option 1x12 Mon) 2026-03-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Formoterol, Beclometason, Glycopyrronium, F. D. Z. 01.11.25 - 31.10.26 (plus Extension Option 1x12 Mon) 2026-03-16
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Iron (parenteral Preparations), Atc B03ac07 F. D. Z. 01.11.25-31.10.27 (plus Extension Option 1x12 Month) 2026-03-16
Germany Medicines With The Active Ingredient Goliumumab (atc: L04ab06) 2026-03-16
Germany Medicines With The Active Ingredient Adalimumab (atc: L04ab04) 2026-03-16
Germany Medicines With The Active Ingredient Certolizumab (atc: L04ab05) 2026-03-16
Germany Medicines With The Active Ingredient Certolizumab (atc: L04ab05) 2026-03-16
Germany Medicines With The Active Ingredient Etannercept (atc: L04ab01) 2026-03-16
Germany Medicines With The Active Ingredient Vareniclin (atc: N07ba03) 2026-03-16
Germany Medicines With The Active Ingredient Infliximab (atc: L04ab02 - In The Dosage Form Powder For The Here. Of An Infusion Solution Concentrate Or Powder For A Concentrate On The Here. 2026-03-16
Whats app